Levetiracetam (Keppra) in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease

  • Theresa A. Zesiewicz
  • , Kelly L. Sullivan
  • , Juan Maldonado
  • , W. O. Tatum
  • , Robert A. Hauser

Research output: Contribution to book or proceedingChapter

Abstract

This conference abstract was published in the Proceedings of the American Academy of Neurology Annual Meeting.
Original languageAmerican English
Title of host publicationProceedings of the American Academy of Neurology Annual Meeting
StatePublished - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Disciplines

  • Public Health

Keywords

  • Dyskinesia
  • Keppra
  • Levetiracetam
  • Levodopa-induced
  • Parkinson's disease
  • Treatment

Fingerprint

Dive into the research topics of 'Levetiracetam (Keppra) in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease'. Together they form a unique fingerprint.

Cite this